Impact of thymoglobulin prior to pediatric unrelated umbilical cord blood transplantation on immune reconstitution and clinical outcome. - Wikidata - wikimedia - TriplyDB

Impact of thymoglobulin prior to pediatric unrelated umbilical cord blood transplantation on immune reconstitution and clinical outcome.

Impact of thymoglobulin prior to pediatric unrelated umbilical cord blood transplantation on immune reconstitution and clinical outcome.

http://www.wikidata.org/entity/Q42258137

about

New directions for rabbit antithymocyte globulin (Thymoglobulin(®)) in solid organ transplants, stem cell transplants and autoimmunity Dendritic Cell Therapy in an Allogeneic-Hematopoietic Cell Transplantation Setting: An Effective Strategy toward Better Disease Control?Antithymocyte globulin treatment at the time of transplantation impairs donor hematopoietic stem cell engraftment.OKT3 prevents xenogeneic GVHD and allows reliable xenograft initiation from unfractionated human hematopoietic tissues.Reconstitution of adaptive immunity after umbilical cord blood transplantation: impact on infectious complications Graft-versus-host disease and survival after cord blood transplantation for acute leukemia: a comparison of Japanese versus White populations The effects of CAMPATH-1H on cell viability do not correlate to the CD52 density on the cell surface High day 28 ST2 levels predict for acute graft-versus-host disease and transplant-related mortality after cord blood transplantation.Cognate CD4 T-cell licensing of dendritic cells heralds anti-cytomegalovirus CD8 T-cell immunity after human allogeneic umbilical cord blood transplantation In Vivo T Cell Depletion with Myeloablative Regimens on Outcomes after Cord Blood Transplantation for Acute Lymphoblastic Leukemia in Children.Robust Vaccine Responses in Adult and Pediatric Cord Blood Transplantation Recipients Treated for Hematologic Malignancies.Differential impact of two doses of antithymocyte globulin conditioning on lymphocyte recovery upon haploidentical hematopoietic stem cell transplantation Umbilical Cord Blood Transplantation Outcomes in Acute Myelogenous Leukemia/Myelodysplastic Syndrome Patients Aged ≥70 Years General and Virus-Specific Immune Cell Reconstitution after Double Cord Blood Transplantation Pharmacokinetics, Pharmacodynamics, and Pharmacogenomics of Immunosuppressants in Allogeneic Hematopoietic Cell Transplantation: Part II.GvHD after umbilical cord blood transplantation for acute leukemia: an analysis of risk factors and effect on outcomes Antithymocyte globulin improves the survival of patients with myelodysplastic syndrome undergoing HLA-matched unrelated donor and haplo-identical donor transplants.Strategies to accelerate immune recovery after allogeneic hematopoietic stem cell transplantation.Immune reconstitution and outcomes after conditioning with anti-thymocyte-globulin in unrelated cord blood transplantation; the good, the bad, and the ugly.GvHD prophylaxis after single-unit reduced intensity conditioning cord blood transplantation in adults with acute leukemia.Stem cell transplantation for the treatment of immunodeficiency in children: current status and hopes for the future.Impact of Graft-Recipient ABO Compatibility on Outcomes after Umbilical Cord Blood Transplant for Nonmalignant Disease.Individualized conditioning regimes in cord blood transplantation: Towards improved and predictable safety and efficacy.Predicting CD4 T-Cell Reconstitution Following Pediatric Hematopoietic Stem Cell Transplantation.Exploratory research for optimal GvHD prophylaxis after single unit CBT in adults: short-term methotrexate reduced the incidence of severe GvHD more than mycophenolate mofetil.Transplantation of CD3/CD19 depleted allografts from haploidentical family donors in paediatric leukaemia.Pre-engraftment bloodstream infections in acute leukemia patients undergoing unrelated cord blood transplantation following intensified myeloablative conditioning without ATG.A trial of unrelated donor marrow transplantation for children with severe sickle cell disease.Advances in umbilical cord blood transplant: an overview of the 12th International Cord Blood Symposium, San Francisco, 5-7 June 2014.Similar survival, but better quality of life after myeloablative transplantation using unrelated cord blood vs matched sibling donors in adults with hematologic malignancies.Umbilical Cord Blood Transplantation in Children with Acute Leukemia: Impact of Conditioning on Transplantation Outcomes.Cord blood chimerism and relapse after haplo-cord transplantation.Population pharmacokinetic modeling of Thymoglobulin(®) in children receiving allogeneic-hematopoietic cell transplantation: towards improved survival through individualized dosing.UK experience of unrelated cord blood transplantation in paediatric patients.Leukemia-free survival in myeloid leukemia, but not in lymphoid leukemia, is predicted by early CD4+ reconstitution following unrelated cord blood transplantation in children: a multicenter retrospective cohort analysis.Haplo-cord transplant: HLA-matching determines graft dominance.

P2860

Q26823090-85B1F767-670B-4C2D-BE35-55718AD76FE4 Q26830857-82042FFB-3E6F-40ED-BCAE-898A2F785665 Q33652103-8CB14DD6-43DE-4387-A4F3-A88769EED002 Q33749684-CDC0B504-FF6C-4FBE-BD71-1FE6E32914FC Q33767001-8821472C-DE04-47B1-916D-5B38DC496BBA Q33810316-CC0CD22D-E4AC-43F6-AD21-C4EBA5202346 Q33933551-6D69E567-32B3-4EF3-92E7-70111B9CDAE6 Q34802425-85FC1FC7-91AA-4B89-87C0-36023FC2D772 Q34991001-9AA291C0-B4CE-498F-93AC-CF9B5D3D769E Q36264735-208C949B-E5CF-4512-B577-63F200789BA5 Q36355144-7875159F-00FB-498F-80BB-0CC69CD20BA0 Q36416597-99BB468E-6129-4128-81ED-DB117BC5DAE3 Q36623075-6185E56B-C1E7-48DA-8583-7495288C2F19 Q36702752-141D3E15-C056-4B44-B843-925B52045F34 Q36777485-F9D85C95-4088-4C54-8E67-45880BFBE950 Q37675185-0ECA11B0-B19E-47A6-9EB1-7173D9B15A9C Q37681792-F658985D-2B1E-42CD-800F-87CE21864CC1 Q38640239-31AA4666-A2A1-459C-AAF9-F107CBE16F63 Q38728525-618AB717-B29C-4F7E-9A9C-0B0CD22414D4 Q38730402-76EA4443-0F27-483F-A4D2-F8E9A4E1F2B2 Q38735833-C60F3AFF-2D8D-4894-9B1D-4D6F5DE8A31E Q38833975-0F5B8621-2089-4ECC-AAB2-B40EB0927571 Q38897538-4C5A75FF-37CD-419E-9573-996DF92B5F97 Q39027873-D965386F-8C46-42E7-B93B-75C2327146FA Q39110465-2AAC7CF0-125F-4474-B7BB-32E0501E9560 Q40174651-533A5D96-57BF-4208-B6C9-6C2AE0481031 Q40490255-961350C3-7E4F-45F7-BE04-46D25DBF05A9 Q40582651-F5A787F4-0BB8-455B-B6D0-CBE86CA5A9B3 Q43668394-C1DC8E22-215D-4170-947D-0DD2FDA6072F Q44059940-D7129AC4-C2FB-492E-AF99-3B5AFBDDEDFB Q46093492-A27F462D-D60B-44EC-AD44-AF901D5BAF42 Q50417473-2202188A-2BA5-4E4D-B12D-FCB54CAB70F3 Q51000653-75316495-FEDA-4C1A-8936-577E88FC7C1E Q52819128-197FB3DB-1D9D-4F78-B97F-9D25B4BD0502 Q53105506-5D27019A-FFCF-4D90-A17E-12514B481289 Q55261861-2927E705-7C17-4258-BFB8-DD9AE35AA287

P2860

Impact of thymoglobulin prior to pediatric unrelated umbilical cord blood transplantation on immune reconstitution and clinical outcome.

http://www.wikidata.org/entity/Q42258137

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Impact of thymoglobulin prior ...... titution and clinical outcome.

@en

Impact of thymoglobulin prior ...... titution and clinical outcome.

@nl

type

label

Impact of thymoglobulin prior ...... titution and clinical outcome.

@en

Impact of thymoglobulin prior ...... titution and clinical outcome.

@nl

prefLabel

Impact of thymoglobulin prior ...... titution and clinical outcome.

@en

Impact of thymoglobulin prior ...... titution and clinical outcome.

@nl

P1433

Q42258137-3FAF5A58-6A15-47F0-A312-88C1EA63D568

P1476

Q42258137-46EC3FD2-1D9F-4207-8337-6570DF53F10E

P2093

Q42258137-106B6E04-F104-4933-A958-DD635CBEA1B0

Q42258137-1C32BC2C-A172-4E7F-8D19-D4A01226A114

Q42258137-21F8C770-CC89-4BCD-9A0E-2670D1C55250

Q42258137-34552DBF-841A-4D01-9930-0805E10ACF7F

Q42258137-3F802C58-2C79-46E9-96F2-0472D07FB104

Q42258137-431628C7-0DDA-42B3-A8FB-0E4B384EA2F8

Q42258137-5C49EFCB-8BCC-4A8E-9E98-E7328E102537

Q42258137-7A0FBB50-2A2F-41E4-9C82-B94F5DE24FAC

Q42258137-82A3F76B-8772-49FC-BA83-754B4C5F83DE

Q42258137-C8CF9F6A-52A2-42B4-8F0F-FFBB0F2DEA58

P304

Q42258137-DB218A4B-2F88-45EA-BE9B-CF54E5F9EC3F

P31

Q42258137-7AE1F106-3066-4488-8A1D-57B272110963

P356

Q42258137-20837793-1A2D-47CB-9747-6B43E2186223

P407

Q42258137-78B32C21-E271-4229-AF3E-F84BEDCD1D5D

P433

Q42258137-C6F67B88-7E5A-45B7-AEF7-CED7BF20CD1A

P478

Q42258137-FD345410-06B0-4141-9BD2-BB6D02F0DC4A

P50

Q42258137-3D44EDA5-87D6-48D4-A1DD-F602F4FCE8CF

P577

Q42258137-F74E2C74-A7E4-47E1-911C-F51A7CE3D4D2

P5875

Q42258137-ACD28682-0980-4C66-BE4C-323CCD2D87FD

P698

Q42258137-9CA816AD-C9E6-4531-B178-F1E9D302F0BF

P356

BLOOD-2013-05-502385

P1433

P1476

Impact of thymoglobulin prior ...... titution and clinical outcome.

@en

P2093

Arianne de Wildt

http://www.w3.org/2001/XMLSchema#string

Caroline A Lindemans

http://www.w3.org/2001/XMLSchema#string

Corinne E Gerhardt

http://www.w3.org/2001/XMLSchema#string

Kanchan Rao

http://www.w3.org/2001/XMLSchema#string

Kimberly C Gilmour

http://www.w3.org/2001/XMLSchema#string

Marc B Bierings

http://www.w3.org/2001/XMLSchema#string

Olga Nikolajeva

http://www.w3.org/2001/XMLSchema#string

Paul Veys

http://www.w3.org/2001/XMLSchema#string

Persis J Amrolia

http://www.w3.org/2001/XMLSchema#string

Robert Chiesa

http://www.w3.org/2001/XMLSchema#string

P304

126-132

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2013-05-502385

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

123

http://www.w3.org/2001/XMLSchema#string

P50

Jaap J. Boelens

P577

2013-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258252843

http://www.w3.org/2001/XMLSchema#string

P698

24184682

http://www.w3.org/2001/XMLSchema#string